Tweaks to Bill | Vaccine Mandate Update

The major questions doctrine has gone from something the Supreme Court used once every five years to a “Swiss Army knife” for courts to limit agency power, Professor Wendy Parmet, director of Northeastern Law’s Center for Health Policy and Law, tells Bloomberg Law.

Biden’s Omicron Booster Campaign Faces Fatigue, Efficacy Doubts

“It would be an extraordinary failure of public policy for Congress not to reauthorize funding to extend government supported access to vaccines, boosters, tests, and therapeutics,” Professor Brook Baker ’76, senior policy analyst for Health GAP, tells Bloomberg Law.

As a Female Trafficker, Ghislaine Maxwell Is Not an Aberration

Professor Margo Lindauer ’07, director of Northeastern Law’s Domestic Violence Institute, doesn’t buy the idea that Ghislaine Maxwell served in court as a proxy for prosecuting Jeffrey Epstein. “He would not be able to do what he did without her," she tells News@Northeastern.

Northeastern Law Graduate Looks To Support Underserved Communities as Intellectual Property Attorney

Simone Yhap ’22, the 55th National Chair of the National Black Law Students Association, is profiled by News@Northeastern. “Whenever I’m leading something or engaged in something, I ask, ‘How is this positively impacting the communities, not only that I’m a part of, but more importantly, that I’m serving?’,” says Yhap who has secured a post-graduation job as an intellectual property litigation associate at Mintz Levin.

Post-Roe, Could States Outlaw Abortion Pills?

Abortion medications are available by mail and offer an FDA-approved option for those hoping to terminate an early pregnancy. If Roe is overturned, could the pills be criminalized? Professor Wendy Parmet weighs in.

Pfizer Allegedly Pressured UNICEF to Keep Secret, Pricing for Anti-Viral Treatment Paxlovid. UNICEF Yielded.

Professor Brook Baker ’76, senior policy analyst for Health GAP, tells Geneva Health Filesthat a negative precedent is being set with respect to transparency for public resources spent in procuring COVID-19 therapeutics: “Not only has the world allowed biopharmaceutical companies to maintain monopoly control over the supply, price, and distribution of COVID-19 countermeasures, it has also consistently allowed them to achieve their profiteering under a veil of secrecy.”